Case report: first case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma

HIGHLIGHTS

  • who: Yongtong Cao and Shiyao Wang from the (EFS), France Istanbul University-Cerrahpasa, Turkey have published the Article: Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma, in the Journal: (JOURNAL) of 26/Nov/2021
  • what: The authors report a patient who developed DIIHA after receiving intravenous infusion of pemetrexed plus cisplatin chemotherapy for lung adenocarcinoma.

SUMMARY

    Serologic testing for associated drug-induced antibodies is very useful for verifying and differentiating the diagnosis of DIIHA. Drugs that interact with the immune system . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?